Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | TLR4 | O00206 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21452802 | 1.00 | ATM (0.48) | ATMALDH1A1KDM4EEPHX2MTNR1A | |
| SCHEMBL15765690 | 1.00 | ATM (0.48) | ATMALDH1A1KDM4EEPHX2MTNR1A | |
| SCHEMBL284319 | 0.89 | ATM (0.56) | ATMALDH1A1KDM4EEPHX2MTNR1A | |
| SCHEMBL284318 | 0.89 | ATM (0.56) | ATMALDH1A1KDM4EEPHX2MTNR1A | |
| SCHEMBL50350 | 0.89 | — | — | |
| SCHEMBL284342 | 0.89 | ATM (0.56) | ATMALDH1A1KDM4EEPHX2MTNR1A | |
| Hydrochloric Acid SCHEMBL27752288 | 0.87 | — | — | |
| Water SCHEMBL27364290 | 0.87 | — | — | |
| SCHEMBL21452830 | 0.86 | ATM (0.50) | ATMALDH1A1KDM4EEPHX2MTNR1A | |
| SCHEMBL13866437 | 0.86 | ATM (0.50) | ATMALDH1A1KDM4EEPHX2MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11914248-B2 | Photo-alignment copolymer, photo-alignment film, and optical laminate | FUJIFILM CORPORATION (JP) | 2024-02-27 | — | — | US | disclosed |
| US-20230217789-A1 | OPTICAL LAMINATE AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-07-06 | — | — | US | disclosed |
| US-20230213695-A1 | LAMINATES, POLARIZING PLATES, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-07-06 | — | — | US | disclosed |
| US-20230217789-A1 | OPTICAL LAMINATE AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-07-06 | — | — | US | disclosed |
| US-11692050-B2 | Photo-alignment copolymer, binder composition, binder layer, optical laminate, and image display device | FUJIFILM CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| WO-2022218379-A1 | SMALL-MOLECULE COMPOUND HAVING SUBSTITUTED PHENYL SPIRO[INDOLINE-3,3'-PYRROLIDINE] STRUCTURE | 中国科学院上海药物研究所 | 2022-10-20 | — | — | WO | disclosed |
| EP-3825313-A1 | PYRIDIN-2(1H)-ONE DERIVATIVES AS BROMODOMAIN INHIBITORS | AbbVie Inc. (US) | 2021-05-26 | — | — | EP | disclosed |
| US-20210047304-A1 | Bromodomain Inhibitors | ABBVIE INC. | 2021-02-18 | — | — | US | disclosed |
| US-20170327509-A1 | TWO-PHOTON ABSORBING FLUOROPHORES AND METHOD FOR CELLULAR IMAGING USING THE SAME | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2017-11-16 | — | — | US | disclosed |
| US-9790221-B2 | Heteroaryl compounds as IRAK inhibitors and uses thereof | MERCK PATENT GMBH (DE) | 2017-10-17 | — | — | US | disclosed |
| US-20080119457-A1 | Benzene, Pyridine, and Pyridazine Derivatives | SERENEX, INC. | 2008-05-22 | — | — | US | disclosed |
| US-20080119457-A1 | Benzene, Pyridine, and Pyridazine Derivatives | SERENEX, INC. | 2008-05-22 | — | — | US | disclosed |
| US-20080076800-A1 | Benzene, Pyridine, and Pyridazine Derivatives | SERENEX, INC. | 2008-03-27 | — | — | US | disclosed |
| US-20080076813-A1 | Benzene, Pyridine, and Pyridazine Derivatives | SERENEX, INC. | 2008-03-27 | — | — | US | disclosed |
| US-20080076813-A1 | Benzene, Pyridine, and Pyridazine Derivatives | SERENEX, INC. | 2008-03-27 | — | — | US | disclosed |
| US-20080076800-A1 | Benzene, Pyridine, and Pyridazine Derivatives | SERENEX, INC. | 2008-03-27 | — | — | US | disclosed |
| US-20080070918-A1 | Dihydropyridazine, Tetrahydropyridine, Chromanone, and Dihydronaphthalenone Derivatives | SERENEX, INC. | 2008-03-20 | — | — | US | disclosed |
| US-20080070918-A1 | Dihydropyridazine, Tetrahydropyridine, Chromanone, and Dihydronaphthalenone Derivatives | SERENEX, INC. | 2008-03-20 | — | — | US | disclosed |
| US-20080070930-A1 | Pyrimidine and Pyrazine Derivatives | SERENEX, INC. | 2008-03-20 | — | — | US | disclosed |
| US-20080070930-A1 | Pyrimidine and Pyrazine Derivatives | SERENEX, INC. | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047304-A1 | Bromodomain Inhibitors | BRD4, BRD1, BRD3 | ATM 1363/4885ALDH1A1 2378/4885KDM4E 683/4885 |
| US-20080070930-A1 | Pyrimidine and Pyrazine Derivatives | P2RX7, P2RX5, P2RX3 | ATM 2064/4885ALDH1A1 986/4885KDM4E 2902/4885 |
| US-20080070918-A1 | Dihydropyridazine, Tetrahydropyridine, Chromanone, and Dihydronaphthalenone Derivatives | QDPR, CCND2, CCND1 | ATM 2747/4885ALDH1A1 143/4885KDM4E 1793/4885 |
| US-20080076800-A1 | Benzene, Pyridine, and Pyridazine Derivatives | RB1, MKI67, CCNB1 | ATM 2009/4885ALDH1A1 767/4885KDM4E 1246/4885 |
| US-20170327509-A1 | TWO-PHOTON ABSORBING FLUOROPHORES AND METHOD FOR CELLULAR IMAGING USING THE SAME | ACE2, DNPEP, ACE | ATM 2836/4885ALDH1A1 298/4885KDM4E 3999/4885 |
| US-20080076813-A1 | Benzene, Pyridine, and Pyridazine Derivatives | MKI67, CCNB1, CCNB3 | ATM 2116/4885ALDH1A1 580/4885KDM4E 1162/4885 |
| US-20080119457-A1 | Benzene, Pyridine, and Pyridazine Derivatives | MKI67, CCNB1, RB1 | ATM 2317/4885ALDH1A1 440/4885KDM4E 1597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.